SMTL ID : 7jmx.1

Crystal structure of a SARS-CoV-2 cross-neutralizing antibody COVA1-16 Fab

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.53 Å

Oligo State

hetero-1-1-mer

Ligands

3 x SO4: SULFATE ION(Non-functional Binders)

SO4.1: 2 residues within 4Å: Chain A: N.52, S.57 3 PLIP interactions: 3 interactions with chain A Hydrogen bonds: A:N.52, A:S.57, A:S.57 SO4.2: 5 residues within 4Å: Chain A: Y.27, T.28, Y.32, R.101 Ligands: ACT.4 5 PLIP interactions: 5 interactions with chain A Hydrogen bonds: A:T.28, A:T.28, A:T.28, A:Y.32 Salt bridges: A:R.101 SO4.3: 1 residues within 4Å: Chain A: S.85 No protein-ligand interaction detected (PLIP)

1 x ACT: ACETATE ION(Non-functional Binders)

ACT.4: 3 residues within 4Å: Chain A: S.31, R.101 Ligands: SO4.2 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:S.31 Salt bridges: A:R.101

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Liu, H. et al., Cross-Neutralization of a SARS-CoV-2 Antibody to a Functionally Conserved Site Is Mediated by Avidity. Immunity (2020)

Release Date

2020-10-14

Peptides

COVA1-16 heavy chain: A
COVA1-16 light chain: B

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
H

B
L

COVA1-16 heavy chain

COVA1-16 light chain

Related Entries With Identical Sequence